Northwell Health Selects Epic to Deliver Next-generation Electronic Health Record

Northwell Health today announced an agreement with health care software leader Epic to implement the health system’s next generation electronic health record (EHR) as part of its ongoing digital transformation to ensure a more seamless patient and team member experience.

Epic, the industry-leading EHR provider based in Wisconsin, provides an integrated solution that will result in one patient record across every Northwell Health venue of care and drive enhanced care coordination. New York State’s largest health system with 21 hospitals and about 900 outpatient facilities expects to roll out the new EHR in phases, with the first go-live occurring in 2025.

“Implementing Epic at Northwell will require a multi-year effort re-visioning the consumer experience, clinical workflow and standards followed by configuration and ultimately activation,” said Joseph Moscola, PA, executive vice president of Enterprise Services at Northwell. “We are at the start of an exciting digital transformation journey, which includes utilizing Google Cloud to discover data insights and refining our customer relationship management to create personalized experiences.”

Northwell is making an investment in an EHR solution that will transform how it delivers care and manages revenue cycle across the enterprise. Using Epic, Northwell will focus on several key areas, including:

• Providing one patient record across ambulatory, emergency, inpatient and post-acute care to improve clinical continuity and care coordination;
• Using a more intuitive platform to reduce the administrative and cognitive burden for clinical and revenue cycle staff;
• Eliminating workflow redundancies and the need for workarounds.

“We are excited for the collaboration and possibilities with Epic,” said Sophy Lu, senior vice president and chief information officer at Northwell. “This is a significant foundational decision to simplify our digital ecosystem in order to enhance the connectedness of Northwell’s integrated system delivery and bring joyful experiences at every touchpoint.”

Providers use Epic software to care for more than 300 million patients worldwide.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version